drugset / Trial / NCT06635317

Efficacy of Aspirin in Preventing Venous Thromboembolism

NCT06635317

RandomizedFactorialSingle-blindTreatment

Summary

Efficacy of aspirin and enoxaparin in preventing venous tromboembolism was compared after total knee or hip arthroplasty.

Timeline

Start
2022-04-24
Primary completion
2022-10-24
Completion
2023-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg Oral
Comparator Enoxaparin sodium Other / unclassified 20 mg Subcutaneous
Comparator Enoxaparin sodium Other / unclassified 40 mg Subcutaneous